Search Results - "Viguria, Maria C"

Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia by Calviño, Cristina, Ceballos, Candela, Alfonso, Ana, Jauregui, Patricia, Calleja-Cervantes, Maria E, San Martin-Uriz, Patxi, Rodriguez-Marquez, Paula, Martin-Mallo, Angel, Iglesias, Elena, Abizanda, Gloria, Rodriguez-Diaz, Saray, Martinez-Turrillas, Rebeca, Illarramendi, Jorge, Viguria, Maria C, Redondo, Margarita, Rifon, Jose, Villar, Sara, Lasarte, Juan J, Inoges, Susana, Lopez-Diaz de Cerio, Ascension, Hernaez, Mikel, Prosper, Felipe, Rodriguez-Madoz, Juan R

“…Despite the potential of CAR-T therapies for hematological malignancies, their efficacy in patients with relapse and refractory Acute Myeloid Leukemia has been…”
Get full text

Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study by Escamilla Gómez, Virginia, García-Gutiérrez, Valentín, López Corral, Lucía, García Cadenas, Irene, Pérez Martínez, Ariadna, Márquez Malaver, Francisco J., Caballero-Velázquez, Teresa, González Sierra, Pedro A., Viguria Alegría, María C., Parra Salinas, Ingrid M., Calderón Cabrera, Cristina, González Vicent, Marta, Rodríguez Torres, Nancy, Parody Porras, Rocío, Ferra Coll, Christelle, Orti, Guillermo, Valcárcel Ferreiras, David, De la Cámara LLanzá, Rafael, Molés, Paula, Velázquez-Kennedy, Kyra, João Mende, María, Caballero Barrigón, Dolores, Pérez, Estefanía, Martino Bofarull, Rodrigo, Saavedra Gerosa, Silvanna, Sierra, Jorge, Poch, Marc, Zudaire Ripa, María T., Díaz Pérez, Miguel A., Molina Angulo, Blanca, Sánchez Ortega, Isabel, Sanz Caballer, Jaime, Montoro Gómez, Juan, Espigado Tocino, Ildefonso, Pérez-Simón, José A

“…Graft-versus-host disease is the main cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation. First-line treatment is based…”
Get full text

Ibrutinib in Combination with R-GemOx in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma of Nongerminal Center B-cell–like Type: Phase II Clinical Trial of the Spanish GELTAMO Group by Rey-Búa, Beatriz, Grande, Carlos, Sánchez Blanco, José J., Abrisqueta, Pau, Gutiérrez, Antonio, Ramírez Páyer, Ángel, Giné, Eva, Zeberio Etxetxipia, Izaskun, Terol, Maria J., de la Cruz Vicente, Fátima, Andreu, Rafel, Ramirez, Maria J., de la Fuente, Adolfo, Viguria, Maria C., Peñarrubia, María J., Jiménez-Ubieto, Ana, Montes-Moreno, Santiago, López-Guillermo, Armando, Caballero, María D., Martín García-Sancho, Alejandro

“…Abstract Purpose: This phase II clinical trial evaluated the combination of ibrutinib with rituximab, gemcitabine, and oxaliplatin (R-GemOx) in patients with…”
Get full text

Long-term prognostic significance of response in multiple myeloma after stem cell transplantation by Martinez-Lopez, Joaquin, Blade, Joan, Mateos, María-Victoria, Grande, Carlos, Alegre, Adrián, García-Laraña, José, Sureda, Anna, de la Rubia, Javier, Conde, Eulogio, Martinez, Rafael, de Arriba, Felipe, Viguria, Maria C., Besalduch, Joan, Cabrera, Rafael, Gonzalez-San Miguel, José D., Guzman-Zamudio, José Luis, Gomez del Castillo, Maria Carmen, Moraleda, José Maria, García-Ruiz, Juan C., San Miguel, Jesús, Lahuerta, Juan José

“…For establishing the true effect of different response categories in patients with multiple myeloma (MM) treated with autologous stem cell transplantation, we…”
Get full text

CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome by Rodriguez-Marquez, Paula, Calleja-Cervantes, Maria E, Serrano, Guillermo, Oliver-Caldes, Aina, Palacios-Berraquero, Maria L, Martin-Mallo, Angel, Calviño, Cristina, Español-Rego, Marta, Ceballos, Candela, Lozano, Teresa, San Martin-Uriz, Patxi, Vilas-Zornoza, Amaia, Rodriguez-Diaz, Saray, Martinez-Turrillas, Rebeca, Jauregui, Patricia, Alignani, Diego, Viguria, Maria C, Redondo, Margarita, Pascal, Mariona, Martin-Antonio, Beatriz, Juan, Manel, Urbano-Ispizua, Alvaro, Rodriguez-Otero, Paula, Alfonso-Pierola, Ana, Paiva, Bruno, Lasarte, Juan J, Inoges, Susana, Lopez-Diaz de Cerio, Ascension, San-Miguel, Jesus, Fernandez de Larrea, Carlos, Hernaez, Mikel, Rodriguez-Madoz, Juan R, Prosper, Felipe

“…Identification of new markers associated with long-term efficacy in patients treated with CAR T cells is a current medical need, particularly in diseases such…”
Get full text

A new prognostic model identifies patients aged 80 years and older with diffuse large B‐cell lymphoma who may benefit from curative treatment: A multicenter, retrospective analysis by the Spanish GELTAMO group by Pardal, Emilia, Díez Baeza, Eva, Salas, Queralt, García, Tomás, Sancho, Juan M., Monzón, Encarna, Moraleda, José M., Córdoba, Raúl, de la Cruz, Fátima, Queizán, José A., Rodríguez, María J., Navarro, Belén, Hernández, José A., Díez, Rosana, Vahi, María, Viguria, María C., Canales, Miguel, Peñarrubia, María J., González‐López, Tomás J., Montes‐Moreno, Santiago, González‐Barca, Eva, Caballero, Dolores, Martín, Alejandro

“…The means of optimally managing very elderly patients with diffuse large B‐cell lymphoma (DLBCL) has not been established. We retrospectively analyzed 252…”
Get full text

Allogeneic hematopoietic stem cell transplantation in patients with multiple myeloma. Impact of disease characteristics, disease status at transplant, and prior number of lines of therapy. Results of retrospective, multicentre Spanish study by Rubia, Javier De La, Pérez, Ariadna, Rosinol, Laura, Arnao, Mario, Teruel, Ana Isabel, Herrera, Inmaculada, Albo, Carmen, Vaz, Carlos, Krisnk, Isabel, Bermudez, Arancha, Pascual, María J., Encinas, Cristina, Cabanas, Valentín, Jurado, Manuel, Gonzalez, Sonia, Viguria, Maria C., Chinea, Anabelle, Ferra, Christelle, Sampol, Antonia, Solano, Carlos, Gonzalez, Marta S.

Get full text